Alto Neuroscience Inc. (ANRO)
NYSE
Real-time Data
01:30 PM
Day's Range
33.6652 wk Range
3.35Overview - ANRO - Alto Neuroscience Inc.
Key Statistics
Valuation
Enterprise Value
1.12B
P/E (Trailing)
‪-15.62‬
P/E (Forward)
‪-10.43‬
PEG Ratio
‪-0.36‬
Price / Book
‪5.48‬
EV / EBITDA
‪-12.84‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-26.78%‬
Return on Equity
‪-49.16%‬
Ownership
Shares Outstanding
35.05M
Float
29.64M
Short % of Shares Outstanding
‪9.77%‬
Held by Insiders
‪4.07%‬
Held by Institutions
‪86.97%‬
Price stats
Beta
‪1.09‬
50-Day Avg
‪27.26‬
200-Day Avg
‪21.07‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
11 analysts
Average price target
‪$ 38.38‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ANRO - Alto Neuroscience Inc.
Peers - ANRO - Alto Neuroscience Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- ANRONYSEAlto Neuroscience Inc.1.34BMarket Cap+88.51%52-week change-15.62P/E (Trailing)‪0.00%‬Profit Margin
- BIONYSEBio-Rad Laboratories Inc.10.16BMarket Cap+21.75%52-week change46.50P/E (Trailing)‪8.58%‬Profit Margin
- BHVNNYSEBiohaven Ltd.2.09BMarket Cap-7.87%52-week change-2.02P/E (Trailing)‪0.00%‬Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.72BMarket Cap+20.82%52-week change6.90P/E (Trailing)‪0.00%‬Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust1.00BMarket Cap+25.06%52-week change4.60P/E (Trailing)‪0.00%‬Profit Margin
- ATTONYSEAttovia Therapeutics Inc.895.00MMarket Cap-5.29%52-week change-8.78P/E (Trailing)‪0.00%‬Profit Margin
- ARMPNYSEArmata Pharmaceuticals Inc.189.62MMarket Cap+49.02%52-week change-1.05P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - ANRO - Alto Neuroscience Inc.
About
Alto Neuroscience Inc. is a biotechnology company that focuses on developing precision therapeutics for psychiatric disorders. The company's primary objective is to utilize advanced neurobiological insights and digital tools to tailor treatments for conditions like depression, anxiety, and other mental health…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
